Sign in

CIK 0001638097

  • Non-accelerated filer
  • Smaller reporting company

Entera Bio Ltd.

Sign in to watch
Ticker
ENTX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Israel
Entity type
Operating
Phone
+972 25327151
Business address
KIRYAT HADASSAH, MINRAV BUILDING, FIFTH FLOOR, JERUSALEM, Israel, 9112002
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-08-07 Rubin Steven D Director Grant or award +19,117 34,117
2026-08-07 Rubin Steven D Director Grant or award · Stock Option (right to buy) +33,368 33,368
2026-08-07 Rubin Steven D Director Grant or award · Stock Option (right to buy) +43,405 43,405
2026-08-07 Malca Yonatan Director Grant or award +22,815 100,231
2026-08-07 Taitel Haya Director Grant or award +20,790 119,269
2026-08-07 Ellis Sean Director Grant or award +20,034 208,132
2026-08-07 Ellis Sean Director Grant or award · Stock Option (right to buy) +40,000 40,000
2026-08-07 Yaacov-Garbeli Dana Chief Financial Officer Grant or award · Stock Option (right to buy) +140,000 140,000
2026-08-07 Galitzer Hillel Chief Operating Officer Grant or award · Stock Option (right to buy) +200,000 200,000
2026-08-07 Burshtein Gregory Chief of R&D Grant or award · Stock Option (right to buy) +180,000 180,000
2026-08-07 Toledano Miranda Jayne Chief Executive Officer Grant or award · Stock Option (right to buy) +500,000 500,000
2026-08-07 Toledano Miranda Jayne Chief Executive Officer Grant or award · Stock Option (right to buy) +200,000 200,000
2026-08-07 Germano Geno J Director Grant or award +25,014 65,014
2026-08-07 Germano Geno J Director Grant or award · Stock Option (right to buy) +50,000 50,000
2026-08-07 Germano Geno J Director Grant or award · Stock Option (right to buy) +43,014 43,014
2026-07-14 Toledano Miranda Jayne Chief Executive Officer Grant or award +347,567 774,142
2026-07-14 Toledano Miranda Jayne Chief Executive Officer Grant or award +72,993 847,135
2026-05-07 Galitzer Hillel Chief Operating Officer Grant or award +72,993 163,566
2026-05-07 Yaacov-Garbeli Dana Chief Financial Officer Grant or award +58,394 171,441
2026-05-07 Burshtein Gregory Chief of R&D Grant or award +87,591 189,033

Page 1 of 8 · 147 trades